跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IMJUDO tremelimumab 300 mg/ 15 mL concentrated injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
IMJUDO tremelimumab 300 mg/ 15 mL concentrated injection vial
Approved
STANDARD
IMJUDO tremelimumab 300 mg/ 15 mL concentrated injection vial
AstraZeneca Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
5ce1dcfb0820ec54
Company
AstraZeneca Pty Ltd
Type
Standard
Approval Details
Approval Id
5ce1dcfb0820ec54
Product Name
IMJUDO tremelimumab 300 mg/ 15 mL concentrated injection vial
Artg Id
387300
Artg Name
IMJUDO tremelimumab 300 mg/ 15 mL concentrated injection vial
Sponsor
AstraZeneca Pty Ltd
Company Detail Path
/organization/astrazeneca-pty-ltd
Artg Date
2023-06-23
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
5ce1dcfb0820ec54
Type
Standard
Back to TGA Approvals
